CD27 Protein (AA 19-188)
Kurzübersicht für CD27 Protein (AA 19-188) (ABIN8127183)
Target
Alle CD27 Proteine anzeigenProtein-Typ
Biologische Aktivität
Spezies
Quelle
Applikation
Reinheit
-
-
Proteineigenschaft
- AA 19-188
-
Verwendungszweck
- Active Tumor Necrosis Factor Receptor Superfamily, Member 7 (TNFRSF7)
-
Sequenz
- Ser19-Asp188
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
STABILITY: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Isoelectric Point: 7.2
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute in 20 mM Tris, 150 mM NaCl ( pH 8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
-
Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
-
Konservierungsmittel
- Dithiothreitol (DTT), Other preservative, ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin and Dithiothreitol (DTT): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
-
-
- CD27 (CD27 Molecule (CD27))
-
Andere Bezeichnung
- Tumor Necrosis Factor Receptor Superfamily, Member 7
-
Hintergrund
- CD27, S152, T14, Tp55, CD27L receptor,
-
Molekulargewicht
- 20kDa
-
UniProt
- P26842
-
Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-